These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 41558)

  • 41. The action of the new beta-adrenoceptor blocker SL 75212 on the metabolic response to insulin-induced hypoglycaemia in man [proceedings].
    Gomeni R; Kilborn JR; Morselli PL; Saunders J; Sönksen PJ
    Br J Clin Pharmacol; 1979 Oct; 8(4):404P. PubMed ID: 41557
    [No Abstract]   [Full Text] [Related]  

  • 42. Design and in vivo evaluation of carvedilol buccal mucoadhesive patches.
    Thimmasetty J; Pandey G; Babu P
    Pak J Pharm Sci; 2008 Jul; 21(3):241-8. PubMed ID: 18614419
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tissue distribution of exaprolol in rat.
    Faberová V; Trnovec T; Zemánek M; Bezek S; Durisová M; Tomcíková O
    Eur J Drug Metab Pharmacokinet; 1985; 10(1):11-3. PubMed ID: 2863149
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The buccal absorption characteristics of fomocaine.
    Temple DJ; Schesmer KR
    Arch Pharm (Weinheim); 1978 Jun; 311(6):485-91. PubMed ID: 581056
    [No Abstract]   [Full Text] [Related]  

  • 45. Absorption of nicotinic acid and nicotinamide across human buccal mucosa in vivo.
    Evered DF; Sadoogh-Abasian F; Patel PD
    Life Sci; 1980 Nov; 27(18):1649-51. PubMed ID: 6449645
    [No Abstract]   [Full Text] [Related]  

  • 46. Thiamine absorption across human buccal mucosa in vivo.
    Evered DF; Mallett C
    Life Sci; 1983 Mar; 32(12):1355-8. PubMed ID: 6834992
    [No Abstract]   [Full Text] [Related]  

  • 47. In vivo receptor binding of iodinated beta-adrenoceptor blockers.
    Eckelman WC; Gibson RE; Vieras F; Rzeszotarski WJ; Francis B; Reba RC
    J Nucl Med; 1980 May; 21(5):436-42. PubMed ID: 6103024
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Identification of urinary metabolites of befunolol in dog and man principally by mass spectrometry (author's transl)].
    Tohno M; Kimura K; Nagahara M; Sakai Y; Ofuji T; Nadai T
    Yakugaku Zasshi; 1979 Sep; 99(9):944-57. PubMed ID: 44723
    [No Abstract]   [Full Text] [Related]  

  • 49. Absorption of the beta-adrenergic-blocking agent, nadolol, by mice, rats, hamsters, rabbits, dogs, monkeys, and man: an unusual species difference.
    Dreyfuss J; Shaw JM; Ross JJ
    Xenobiotica; 1978 Aug; 8(8):503-8. PubMed ID: 29379
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Does the beta 1-adrenoceptor blocking agent celiprolol have alpha 2-adrenoceptor blocking properties?
    Pittner H
    Arch Int Pharmacodyn Ther; 1987 Feb; 285(2):199-210. PubMed ID: 2883946
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effects of the new beta-adrenoceptor blocker SL 75212 on the cardiovascular responses to insulin induced hypoglycaemia in man [proceedings].
    Kilborn JR; Morselli PL; Saunders J; Sönksen PH
    Br J Clin Pharmacol; 1979 Oct; 8(4):409P. PubMed ID: 41561
    [No Abstract]   [Full Text] [Related]  

  • 52. [The metabolism of 1-tertiary-butylamino-3-(2,3-dimethylphenoxy)-2-propanol (D-32), a new beta-blocker agent. II. Blood level, distribution, and structure of its metabolites in bile (author's transl)].
    Honma S; Kanbekawa A
    Yakugaku Zasshi; 1975 Jun; 95(6):680-9. PubMed ID: 241825
    [No Abstract]   [Full Text] [Related]  

  • 53. [The pharmacokinetics of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane (talinolol, Cordanum, 02-115) 2. Excretion, blood level and distribution of the 14C-labeled compound in the rat].
    Klemm W; Wenzel A
    Pharmazie; 1975 Oct; 30(10):675-7. PubMed ID: 695
    [No Abstract]   [Full Text] [Related]  

  • 54. Formation of a carbamoyl glucuronide conjugate of carvedilol in vitro using dog and rat liver microsomes.
    Schaefer WH
    Drug Metab Dispos; 1992; 20(1):130-3. PubMed ID: 1346989
    [No Abstract]   [Full Text] [Related]  

  • 55. Influence of pH on absorption of thymoxamine through buccal mucosa in man.
    Arbab AG; Turner P
    Br J Pharmacol; 1971 Oct; 43(2):479P-480P. PubMed ID: 5158249
    [No Abstract]   [Full Text] [Related]  

  • 56. Absorption of buccal morphine. A comparison with slow-release morphine sulphate.
    Fisher AP; Fung C; Hanna M
    Anaesthesia; 1988 Jul; 43(7):552-3. PubMed ID: 3414915
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Kinetics of buccal absorption of amphetamines.
    Beckett AH BOYES RN; Triggs EJ
    J Pharm Pharmacol; 1968 Feb; 20(2):92-7. PubMed ID: 4384554
    [No Abstract]   [Full Text] [Related]  

  • 58. Noncholine esterases and cholinesterases.
    Lee C
    J Clin Anesth; 1994; 6(2):166. PubMed ID: 7911307
    [No Abstract]   [Full Text] [Related]  

  • 59. The influence of pH on the buccal absorption and renal excretion of disopyramide in man.
    Ankier SI; Kaye CM
    Br J Clin Pharmacol; 1976 Aug; 3(4):672-3. PubMed ID: 22216514
    [No Abstract]   [Full Text] [Related]  

  • 60. Buccal tissues and cell culture.
    Quadros E; Cassidy JP; Leipold H
    Pharm Biotechnol; 1996; 8():103-13. PubMed ID: 8791807
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.